Brief: Ecor1 Capital, LLC Reports 9.9% Passive Stake In Atara Biotherapeutics As Of Nov 16
21/11/2023 18:51
Nov 21 (Reuters) - Ecor1 Capital, LLC:
* ECOR1 CAPITAL, LLC REPORTS 9.9% PASSIVE STAKE IN ATARA
BIOTHERAPEUTICS AS OF NOVEMBER 16- SEC FILING
Further company coverage: ATRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atara Biotherapeutics
See all newsAtara Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atara Biotherapeutics Q2 revenue falls on deferred revenue recognition
Brief: Atara Biotherapeutics Q2 EPS USD -0.32
Atara Biotherapeutics, Inc. expected to post a loss of 31 cents a share - Earnings Preview
Brief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing